• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝门部胆管癌的病理解剖特征。分类、当前分子生物学方面、预后因素]

[Pathological anatomical characteristics of Klatskin tumors. Classification, current molecular biological aspects, prognosis factors].

作者信息

Munding J, Tannapfel A

机构信息

Institut für Pathologie, BG-Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789 Bochum.

出版信息

Chirurg. 2012 Mar;83(3):208-14. doi: 10.1007/s00104-011-2175-8.

DOI:10.1007/s00104-011-2175-8
PMID:22290222
Abstract

Klatskin tumors are a distinct subgroup of cholangiocarcinomas which are a surgical challenge due to their special localization. Different localizations do not show great differences concerning histomorphology and precursor lesions. With respect to molecular alterations there are only small differences. Accurate clinical and histomorphological diagnosis is important for therapy and especially the prediction of prognosis as well as standardized processing of the resection specimen if the carcinoma is resectable. Additionally, accurate lymph node dissection is necessary. Concerning molecular markers further investigations are needed to develop individualized therapy regimes.

摘要

肝门部胆管癌是胆管癌的一个独特亚组,因其特殊的定位给手术带来挑战。不同的定位在组织形态学和前驱病变方面并无显著差异。在分子改变方面,差异也很小。准确的临床和组织形态学诊断对于治疗,尤其是预后预测以及对可切除癌的切除标本进行标准化处理很重要。此外,准确的淋巴结清扫是必要的。关于分子标志物,还需要进一步研究以制定个体化治疗方案。

相似文献

1
[Pathological anatomical characteristics of Klatskin tumors. Classification, current molecular biological aspects, prognosis factors].[肝门部胆管癌的病理解剖特征。分类、当前分子生物学方面、预后因素]
Chirurg. 2012 Mar;83(3):208-14. doi: 10.1007/s00104-011-2175-8.
2
[Klatskin tumors: rational diagnostics and staging].[肝门部胆管癌:合理的诊断与分期]
Chirurg. 2012 Mar;83(3):215-20. doi: 10.1007/s00104-011-2176-7.
3
Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?肝门部胆管癌累及肝门部与肝门部胆管癌根治性切除术后的长期预后和预后因素:是否应将其视为肝门周围胆管癌或加以区分?
Eur J Surg Oncol. 2019 Nov;45(11):2173-2179. doi: 10.1016/j.ejso.2019.06.014. Epub 2019 Jun 11.
4
p53 mutagenesis in Klatskin tumors.
Hum Pathol. 1998 Sep;29(9):955-60. doi: 10.1016/s0046-8177(98)90200-3.
5
[Importance of the lymph node status in patients with hilar cholangiocarcinoma].
Chirurg. 2017 Apr;88(4):345. doi: 10.1007/s00104-017-0419-y.
6
[Gallbladder and bile duct carcinoma. Biology and pathology].[胆囊和胆管癌。生物学与病理学]
Internist (Berl). 2004 Jan;45(1):33-41. doi: 10.1007/s00108-003-1110-6.
7
Perihilar cancer.
J Am Coll Surg. 2002 Apr;194(4):551. doi: 10.1016/s1072-7515(02)01114-6.
8
[Liver transplantation for hilar cholangiocarcinoma].[肝门部胆管癌的肝移植]
Chirurg. 2012 Mar;83(3):229-37. doi: 10.1007/s00104-011-2178-5.
9
Favourable anatomical variation for the resection of a Klatskin tumour.用于切除肝门部胆管癌的有利解剖变异。
Eur J Surg Oncol. 1996 Feb;22(1):97-101. doi: 10.1016/s0748-7983(96)91814-4.
10
Resection and bypass for malignant obstruction of the bile duct.胆管恶性梗阻的切除术和旁路手术。
World J Surg. 1995 Jan-Feb;19(1):108-12. doi: 10.1007/BF00316991.

本文引用的文献

1
[Anatomy of the liver. What does the radiologist need to know?].
Radiologe. 2011 Aug;51(8):655-60. doi: 10.1007/s00117-010-2123-5.
2
New insights on cholangiocarcinoma.胆管癌的新见解。
World J Gastrointest Oncol. 2010 Mar 15;2(3):136-45. doi: 10.4251/wjgo.v2.i3.136.
3
Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.肝内、肝门部和远端胆管癌手术切除后的预后因素。
Ann Surg Oncol. 2011 Mar;18(3):651-8. doi: 10.1245/s10434-010-1325-4. Epub 2010 Oct 14.
4
Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience.肝门部胆管癌:纪念斯隆-凯特琳癌症中心的经验。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):490-6. doi: 10.1007/s00534-009-0205-4. Epub 2009 Oct 6.
5
Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract.胆道癌中染色体和转录突变的全基因组分析及临床相关性
J Exp Clin Cancer Res. 2009 May 12;28(1):62. doi: 10.1186/1756-9966-28-62.
6
Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions.肝外胆管癌:比较接受近端和远端病变切除术的患者。
HPB (Oxford). 2008;10(5):341-6. doi: 10.1080/13651820802276630.
7
Pathological aspects of cholangiocarcinoma.胆管癌的病理学方面。
HPB (Oxford). 2008;10(2):83-6. doi: 10.1080/13651820801992609.
8
Mechanisms of biliary carcinogenesis and growth.胆管癌发生与生长的机制。
World J Gastroenterol. 2008 May 21;14(19):2986-9. doi: 10.3748/wjg.14.2986.
9
Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.肿块形成加肝内胆管癌导管周围浸润型的手术结果:与典型肿块形成型肝内胆管癌的比较研究
World J Surg. 2007 Oct;31(10):2016-22. doi: 10.1007/s00268-007-9194-0.
10
Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.肝外胆管癌手术切除患者胆管切缘状态的意义
World J Surg. 2007 Sep;31(9):1788-1796. doi: 10.1007/s00268-007-9102-7. Epub 2007 Jul 25.